IMV Inc. re-establishes At-The-Market facility

Date Closed

October 16, 2020

Lead Office

Québec City


50.00 Million USD

On October 16, 2020 IMV Inc. announced that it has entered into an equity distribution agreement with Piper Sandler & Co. Under this agreement, Piper Sandler will act as agent and IMV may sell its common shares through at-the-market offerings for an aggregate offering price of US$50 million.

IMV, a clinical-stage biopharmaceutical company, will use the funds raised by this offering for general corporate purposes, including but not limited to working capital expenditures, capital expenditures, research and development expenditures, COVID-19 vaccine candidate expenditures, and clinical trial expenditures.

McCarthy Tétrault acted as Canadian counsel to IMV with a team led by Philippe Leclerc and included Myreille Gilbert and Annie Poirier-Simard.